NCT06810492 2025-03-17
The Efficacy and Safety of CDK4/6 Inhibitors in Combination with Endocrine Therapy in the Neoadjuvant Treatment
Hubei Cancer Hospital
Phase NA Not yet recruiting
Hubei Cancer Hospital
Fudan University
UNICANCER
Peter MacCallum Cancer Centre, Australia
Zhejiang Cancer Hospital